Literature DB >> 29273946

A Randomized Controlled Trial of Intensive Case Management (Project Bridge) for HIV-Infected Probationers and Parolees.

Michael S Gordon1, Erika L Crable2, Steven B Carswell3, Jessica Leopold4, Jennifer Hodo-Powell4, Michelle McKenzie5, Josiah D Rich5.   

Abstract

Individuals on probation and parole are disproportionately at high risk for HIV infection and experience significant barriers to accessing health care. This study was a two-group randomized controlled trial conducted at a community corrections office and was designed to link HIV positive probationers/parolees to HIV treatment in the community. HIV positive participants were assigned to one of the two treatment conditions: (1) Project Bridge (PB), an intensive case-management intervention; or (2) treatment as usual (TAU), involving standard referral to treatment. We hypothesized that PB would be more effective than TAU in terms of initiating individuals in community HIV treatment. We found no difference in rates of, or time to, treatment initiation when comparing the PB to TAU (all ns > 0.05). Additionally, there was no statistically significant difference between HIV medication regiment initiation by treatment condition (p > 0.05). Despite limitations, we found that probationers and parolees were willing to be screened and linked to treatment.

Entities:  

Keywords:  Case management; Community HIV treatment; Parole; Probation

Mesh:

Year:  2018        PMID: 29273946      PMCID: PMC5828983          DOI: 10.1007/s10461-017-2016-y

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  32 in total

1.  Correlates of retention in HIV care after release from jail: results from a multi-site study.

Authors:  Amy L Althoff; Alexei Zelenev; Jaimie P Meyer; Jeannia Fu; Shan-Estelle Brown; Panagiotis Vagenas; Ann K Avery; Jacqueline Cruzado-Quiñones; Anne C Spaulding; Frederick L Altice
Journal:  AIDS Behav       Date:  2013-10

2.  Injection risk behaviors among rural drug users: implications for HIV prevention.

Authors:  Jennifer R Havens; Carrie B Oser; Carl G Leukefeld
Journal:  AIDS Care       Date:  2011-05

3.  Enrollment in outpatient care among newly released prison inmates with HIV infection.

Authors:  Jacques G Baillargeon; Thomas P Giordano; Amy Jo Harzke; Gwen Baillargeon; Josiah D Rich; David P Paar
Journal:  Public Health Rep       Date:  2010 Jan-Feb       Impact factor: 2.792

4.  HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study.

Authors:  Jaimie P Meyer; Javier Cepeda; Sandra A Springer; Johnny Wu; Robert L Trestman; Frederick L Altice
Journal:  Lancet HIV       Date:  2014-11-01       Impact factor: 12.767

5.  Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II.

Authors:  Jason A Craw; Lytt I Gardner; Gary Marks; Richard C Rapp; Jeff Bosshart; Wayne A Duffus; Amber Rossman; Susan L Coughlin; DeAnn Gruber; Lauretta A Safford; Jon Overton; Karla Schmitt
Journal:  J Acquir Immune Defic Syndr       Date:  2008-04-15       Impact factor: 3.731

6.  HIV, STD, and hepatitis risk behaviors of young men before and after incarceration.

Authors:  K M Morrow
Journal:  AIDS Care       Date:  2009-02

7.  Patient navigation facilitates medical and social services engagement among HIV-infected individuals leaving jail and returning to the community.

Authors:  Kimberly A Koester; Mark Morewitz; Charles Pearson; John Weeks; Rebecca Packard; Milton Estes; Jacqueline Tulsky; Mi Suk Kang-Dufour; Janet J Myers
Journal:  AIDS Patient Care STDS       Date:  2014-02       Impact factor: 5.078

8.  Accessing antiretroviral therapy following release from prison.

Authors:  Jacques Baillargeon; Thomas P Giordano; Josiah D Rich; Z Helen Wu; Katherine Wells; Brad H Pollock; David P Paar
Journal:  JAMA       Date:  2009-02-25       Impact factor: 56.272

9.  The impact of antiretroviral therapy in a cohort of HIV infected patients going in and out of the San Francisco county jail.

Authors:  Nitika Pant Pai; Milton Estes; Erica E M Moodie; Arthur L Reingold; Jacqueline P Tulsky
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

10.  Multilevel challenges to engagement in HIV care after prison release: a theory-informed qualitative study comparing prisoners' perspectives before and after community reentry.

Authors:  Danielle F Haley; Carol E Golin; Claire E Farel; David A Wohl; Anna M Scheyett; Jenna J Garrett; David L Rosen; Sharon D Parker
Journal:  BMC Public Health       Date:  2014-12-09       Impact factor: 3.295

View more
  5 in total

1.  Age-Standardized Mortality of Persons on Probation, in Jail, or in State Prison and the General Population, 2001-2012.

Authors:  Christopher Wildeman; Alyssa W Goldman; Emily A Wang
Journal:  Public Health Rep       Date:  2019-10-11       Impact factor: 2.792

2.  Incarceration History and HIV Care Among Individuals Living with HIV in Florida, 2014-2018.

Authors:  Gladys E Ibañez; Zhi Zhou; Angel B Algarin; Disler V Ayala; Emma C Spencer; Charurut Somboonwit; Greg Matthew Teo; Robert L Cook
Journal:  AIDS Behav       Date:  2021-05-06

3.  Effect of Case Management on HIV Outcomes for Community Corrections Population: Results of an 18-Month Randomized Controlled Trial.

Authors:  Erika L Crable; Thomas R Blue; Michelle McKenzie; Josiah D Rich; Michael S Gordon
Journal:  J Acquir Immune Defic Syndr       Date:  2021-05-01       Impact factor: 3.771

4.  Harmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder research.

Authors:  Michelle A Papp; Jared A Leff; Sean M Murphy; April Yang; Heidi M Crane; Lisa R Metsch; Carlos Del Rio; Daniel J Feaster; Josiah D Rich; Bruce R Schackman; Kathryn E McCollister
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-04-08

5.  Interventions to Improve HIV Care Continuum Outcomes Among Individuals Released From Prison or Jail: Systematic Literature Review.

Authors:  Daniel M Woznica; Nimasha B Fernando; Elizabeth J Bonomo; Jill Owczarzak; Barry Zack; Christopher J Hoffmann
Journal:  J Acquir Immune Defic Syndr       Date:  2021-03-01       Impact factor: 3.771

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.